Vaginal adenosarcoma arising from refractory endometriosis: a case report.
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Xiaoyan
X
Han
Jinhua
J
Leng
Lina
L
Guo
Yang
Y
Xiang
Jinghe
J
Lang
D000232:Adenofibroma / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018195:Adenosarcoma / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D018394:CA-125 Antigen / Q000032:analysis; D002945:Cisplatin / Q000627:therapeutic use; D004715:Endometriosis / Q000150:complications* / Q000601:surgery; D015251:Epirubicin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D005867:Gestrinone / Q000627:therapeutic use; D006801:Humans; D007044:Hysterectomy; D007069:Ifosfamide / Q000627:therapeutic use; D008565:Membrane Proteins / Q000032:analysis; D010052:Ovariectomy; D058994:Salpingectomy; D016896:Treatment Outcome; D014625:Vaginal Neoplasms / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D018394:CA-125 Antigen; C451759:MUC16 protein, human; D008565:Membrane Proteins; D001761:Bleomycin; D005867:Gestrinone; D015251:Epirubicin; C025703:bleomycetin; D014750:Vincristine; D005047:Etoposide; D002945:Cisplatin; D007069:Ifosfamide